The Journal of Cell Biology, Vol 110, 777-787, Copyright © 1990 by The Rockefeller University Press

ARTICLES

RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities

JB McCarthy, AP Skubitz, Z Qi, XY Yi, DJ Mickelson, DJ Klein and LT Furcht
University of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis.

Cell adhesion to extracellular matrix components such as fibronectin has a complex basis, involving multiple determinants on the molecule that react with discrete cell surface macromolecules. Our previous results have demonstrated that normal and transformed cells adhere and spread on a 33-kD heparin binding fragment that originates from the carboxy-terminal end of particular isoforms (A-chains) of human fibronectin. This fragment promotes melanoma adhesion and spreading in an arginyl-glycyl-aspartyl-serine (RGDS) independent manner, suggesting that cell adhesion to this region of fibronectin is independent of the typical RGD/integrin-mediated binding. Two synthetic peptides from this region of fibronectin were recently identified that bound [3H]heparin in a solid-phase assay and promoted the adhesion and spreading of melanoma cells (McCarthy, J. B., M. K. Chelberg, D. J. Mickelson, and L. T. Furcht. 1988. Biochemistry. 27:1380-1388). The current studies further define the cell adhesion and heparin binding properties of one of these synthetic peptides. This peptide, termed peptide I, has the sequence YEKPGSP-PREVVPRPRPGV and represents residues 1906-1924 of human plasma fibronectin. In addition to promoting RGD-independent melanoma adhesion and spreading in a concentration-dependent manner, this peptide significantly inhibited cell adhesion to the 33-kD fragment or intact fibronectin. Polyclonal antibodies generated against peptide I also significantly inhibited cell adhesion to the peptide, to the 33-kD fragment, but had minimal effect on melanoma adhesion to fibronectin. Anti-peptide I antibodies also partially inhibited [3H]heparin binding to fibronectin, suggesting that peptide I represents a major heparin binding domain on the intact molecule. The cell adhesion activity of another peptide from the 33-kD fragment, termed CS1 (Humphries, M. J., A. Komoriya, S. K. Akiyama, K. Olden, and K. M. Yamada. 1987. J. Biol. Chem., 262:6886-6892) was contrasted with peptide I. Whereas both peptides promoted RGD-independent cell adhesion, peptide CS1 failed to bind heparin, and exogenous peptide CS1 failed to inhibit peptide I-mediated cell adhesion. The results demonstrate a role for distinct heparin-dependent and -independent cell adhesion determinants on the 33-kD fragment, neither of which are related to the RGD-dependent integrin interaction with fibronectin.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Weiger, M. C., Wang, C.-C., Krajcovic, M., Melvin, A. T., Rhoden, J. J., Haugh, J. M. (2009). Spontaneous phosphoinositide 3-kinase signaling dynamics drive spreading and random migration of fibroblasts. J. Cell Sci. 122: 313-323 [Abstract] [Full Text]  
• Mostafavi-Pour, Z., Askari, J. A., Parkinson, S. J., Parker, P. J., Ng, T. T.C., Humphries, M. J. (2003). Integrin-specific signaling pathways controlling focal adhesion formation and cell migration. JCB 161: 155-167 [Abstract] [Full Text]  
• Santas, A. J., Peterson, J. A., Halbleib, J. L., Craig, S. E., Humphries, M. J., Peters, D. M. P. (2002). Alternative Splicing of the IIICS Domain in Fibronectin Governs the Role of the Heparin II Domain in Fibrillogenesis and Cell Spreading. J. Biol. Chem. 277: 13650-13658 [Abstract] [Full Text]  
• Hu, W.-J., Eaton, J. W., Ugarova, T. P., Tang, L. (2001). Molecular basis of biomaterial-mediated foreign body reactions. Blood 98: 1231-1238 [Abstract] [Full Text]  
• Smorenburg, S. M., Van Noorden, C. J. F. (2001). The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies. Pharmacol. Rev. 53: 93-106 [Abstract] [Full Text]  
• Liu, S., Hoke, D., Julian, J., Carson, D. D. (1997). Heparin/Heparan Sulfate (HP/HS) Interacting Protein (HIP) Supports Cell Attachment and Selective, High Affinity Binding of HP/HS. J. Biol. Chem. 272: 25856-25862 [Abstract] [Full Text]  
• Mohri, H., Tanabe, J., Katoh, K., Okubo, T. (1996). Identification of a Novel Binding Site to the Integrin alpha IIbbeta 3 Located in the C-terminal Heparin-binding Domain of Human Plasma Fibronectin. J. Biol. Chem. 271: 15724-15728 [Abstract] [Full Text]  
• Huebsch, J. C., McCarthy, J. B., Diglio, C. A., Mooradian, D. L. (1995). Endothelial Cell Interactions With Synthetic Peptides From the Carboxyl-Terminal Heparin-Binding Domains of Fibronectin. Circ. Res. 77: 43-53 [Abstract] [Full Text]  
• Pesheva, P, Probstmeier, R, Skubitz, A., McCarthy, J., Furcht, L., Schachner, M (1994). Tenascin-R (J1 160/180 inhibits fibronectin-mediated cell adhesion--functional relatedness to tenascin-C. J. Cell Sci. 107: 2323-2333 [Abstract]  
• McCarthy, J., Turley, E.A. (1993). Effects of Extracellular Matrix Components on Cell Locomotion. CROBM 4: 619-637 [Abstract] [Full Text]  
• Uitto, V.-J., Larjava, H., Peltonen, J., Brunette, D.M. (1992). Expression of Fibronectin and Integrins in Cultured Periodontal Ligament Epithelial Cells. JDR 71: 1203-1211 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents